Millendo Therapeutics Inc (MLND) Stock

DelistedNasdaq: MLNDAs of June 25, 2021, Millendo Therapeutics, Inc.

3.29
Final close · Feb 18, 2022

MLND is no longer traded. Millendo Therapeutics was delisted from the Nasdaq in February 2022.

Prices on this page are historical; the last trade was February 18, 2022 at $3.29.

Millendo Therapeutics stock price history

Split-adjusted closes, 2012–2022

MLND final trading statistics

Final close
$3.29
Final trading day
Feb 18, 2022
Market cap at delisting
$20.19M
Shares outstanding
19.04M
Final 52-week range
$0.92 – $41.00
Avg. volume (final 3 mo.)
30,804
All-time high (split-adj.)
$12028.50 · Mar 2015
All-time low (split-adj.)
$3.05 · Feb 2022
Return since IPO
-99.8%
Beta
0.48
Book value / share
$19.66
Price / book
0.17
Final 52 wk
0.9241.00

Millendo Therapeutics earnings per share

Earnings per share

Millendo Therapeutics revenue & net income

RevenueNet income

Millendo Therapeutics annual financials

Millendo Therapeutics Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2020$0.00-$36.4M-$1.94
FY2019$0.00-$44.6M-$3.26
FY2018$0.00-$27.2M-$9.53
FY2017$295.0K-$51.0M-$21.45
FY2016$653.0K-$82.3M-$9.31

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Millendo Therapeutics Inc

As of June 25, 2021, Millendo Therapeutics, Inc. was acquired by Tempest Therapeutics Inc., in a reverse merger transaction. Millendo Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Ann Arbor, Michigan.

Millendo Therapeutics stock FAQ

What happened to Millendo Therapeutics stock?

Millendo Therapeutics stock was delisted from the Nasdaq. Its final close was $3.29 on February 18, 2022.

Is MLND stock still trading?

No. MLND was delisted from the Nasdaq in February 2022 and no longer trades on a U.S. exchange.

What was the last price of MLND stock?

MLND closed at $3.29 on its final trading day, February 18, 2022, for a market value of about $20.19M.

What were Millendo Therapeutics's revenue and earnings in its last full fiscal year?

Millendo Therapeutics reported revenue of $0.00 and net income of -$36.4M in fiscal 2020, its last full year as a public company.

When did Millendo Therapeutics go public?

Millendo Therapeutics Inc stock began trading on November 12, 2012.

Biotechnology stocks to research

All Healthcare stocks →